Poland· PL-100511967
Theralugand
A other therapeutic radiopharmaceuticals product containing lutetii chloridum [177lu], registered in Poland by Eckert & Ziegler Radiopharma GmbH. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lutetii chloridum [177lu] is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Lutetii chloridum [177lu] · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Lutetii chloridum [177Lu]
- Manufacturer
- Eckert & Ziegler Radiopharma GmbH
- Country
- Poland (PL)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04262485270088
- gtin04262485270095
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V10X
Other therapeutic radiopharmaceuticals, as other registers publish it.
- FinlandEndolucinBetaITM Medical Isotopes GmbH
- PolandEndolucinBetaITM Medical Isotopes GmbH
- IcelandEndolucinBetaITM Medical Isotopes GmbH
- DenmarkEndolucinBetaITM Medical Isotopes GmbH
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- CzechiaENDOLUCINBETAITM Medical Isotopes GmbH, Garching
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
- BelgiumEndolucinBeta 40 GBq/mlITM Medical Isotopes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fba16e18-32ff-40cb-98a2-1630a59a865e GET /v1/drugs/fba16e18-32ff-40cb-98a2-1630a59a865e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prekursor radiofarmaceutyku, roztwór",
"source": "urpl",
"strength": "40 GBq/ml",
"packaging": "04262485270088 ¦ Rpz ¦ EU/1/24/1852/001 ¦ 159948\n1 fiol. 3 ml\n04262485270095 ¦ Rpz ¦ EU/1/24/1852/002 ¦ 159949\n1 fiol. 10 ml",
"substance": "Lutetii (177Lu) Chloridum 40 GBq/ml",
"common_name": "Lutetii chloridum [177Lu]",
"pl_product_id": "100511967",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about lutetii chloridum [177lu].
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.